AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 279: G1011-G1022, 2000;
0193-1857/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, D. S.
Right arrow Articles by Sartor, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, D. S.
Right arrow Articles by Sartor, R. B.
Vol. 279, Issue 5, G1011-G1022, November 2000

Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats

Dong Soo Han1, Fengling Li1, Lisa Holt1, Kevin Connolly2, Melissa Hubert2, Reneé Miceli2, Zebedee Okoye2, Gemma Santiago2, Kathleen Windle2, Eling Wong2, and R. Balfour Sartor1

1 Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina 27599; and 2 Human Genome Sciences, Incorporated, Rockville, Maryland 20850

Keratinocyte growth factor-2 (KGF-2, repifermin) is a homolog of KGF-1 with epithelial mitogenic activities. We investigated the therapeutic role of KGF-2 in intestinal ulceration and its mechanisms of protection. KGF-2 (0.3-5 mg/kg) was administered before or after induction of small intestinal ulceration by indomethacin (Indo) in prevention and treatment protocols. In acute studies, KGF-2 was injected for up to 7 days before or daily for 5 days after Indo. In a 15-day chronic study, KGF-2 was injected intravenously daily beginning before or 7 days after Indo. Injury was evaluated by blinded macroscopic and microscopic inflammatory scores, epithelial BrdU staining, tissue IL-1beta , PGE2, and hydroxyproline concentrations, and collagen type I RNA expression. In vitro effects of KGF-2 were evaluated by epithelial cellular proliferation, restitution of wounded monolayers, PGE2 secretion, and expression of COX-2 and collagen mRNA. Intravenous KGF-2 significantly decreased acute intestinal injury by all parameters and significantly decreased chronic ulceration. Pretreatment, daily infusion, and delayed treatment were effective. KGF-2 promoted in vitro epithelial restitution with only modest effects on epithelial cell proliferation, stimulated COX-2 expression in cultured epithelial cells, and upregulated in vitro and in vivo PGE2 production. KGF-2 did not affect in vivo fibrosis, although it induced collagen expression in cultured intestinal myofibroblasts. These results suggest that KGF-2 inhibits intestinal inflammation by stimulating epithelial restitution and protective PGs.

immunoregulation; inflammatory bowel disease; cytokines; prostaglandins


This article has been cited by other articles:


Home page
Cancer Res.Home page
R. Tammali, K. V. Ramana, S. S. Singhal, S. Awasthi, and S. K. Srivastava
Aldose Reductase Regulates Growth Factor-Induced Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Colon Cancer Cells
Cancer Res., October 1, 2006; 66(19): 9705 - 9713.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
B. K DIECKGRAEFE, J. R KORZENIK, and S. ANANT
Growth factors as treatment options for intestinal inflammation.
Ann. N.Y. Acad. Sci., August 1, 2006; 1072: 300 - 306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Portnoy, T. Pan, C. A. Dinarello, J. M. Shannon, J. Y. Westcott, L. Zhang, and R. J. Mason
Alveolar type II cells inhibit fibroblast proliferation: role of IL-1{alpha}
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L307 - L316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. W. Powell, P. A. Adegboyega, J. F. Di Mari, and R. C. Mifflin
Epithelial Cells and Their Neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer
Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G2 - G7.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. O. Freytes, V. Ratanatharathorn, C. Taylor, C. Abboud, N. Chesser, A. Restrepo, J. Arango, and D. Odenheimer
Phase I/II Randomized Trial Evaluating the Safety and Clinical Effects of Repifermin Administered to Reduce Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
Clin. Cancer Res., December 15, 2004; 10(24): 8318 - 8324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. D Tran, G. S Howarth, P. Coyle, J. C Philcox, A. M Rofe, and R. N Butler
Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine
Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1296 - 1303.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol, R. A. Somer, J. Gutheil, R. J. Pelley, M. R. Modiano, E. K. Rowinsky, M. L. Rothenberg, S. W. Redding, C. M. Serdar, B. Yao, et al.
Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant
J. Clin. Oncol., April 15, 2003; 21(8): 1452 - 1458.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ruehl, R. Somasundaram, I. Schoenfelder, R. W. Farndale, C. G. Knight, M. Schmid, R. Ackermann, E. O. Riecken, M. Zeitz, and D. Schuppan
The Epithelial Mitogen Keratinocyte Growth Factor Binds to Collagens via the Consensus Sequence Glycine-Proline-Hydroxyproline
J. Biol. Chem., July 19, 2002; 277(30): 26872 - 26878.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online